Cargando…
Patient Outcomes on Day 4 of Intravenous Antibiotic Therapy in Non–Intensive Care Unit Hospitalized Adults With Community-Acquired Bacterial Pneumonia
BACKGROUND: Community-acquired bacterial pneumonia (CABP) is a leading cause of morbidity and mortality especially in hospitalized patients. In place of clinical end points traditionally used to evaluate antimicrobial efficacy for its treatment, Food and Drug Administration guidelines now require al...
Autores principales: | Robinson, Scott B., Ernst, Frank R., Lipkin, Craig, Huang, Xingyue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott, Williams & Wilkins
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232336/ https://www.ncbi.nlm.nih.gov/pubmed/25411532 http://dx.doi.org/10.1097/IPC.0000000000000143 |
Ejemplares similares
-
Overprescription of antibiotics in patients with community-acquired pneumonia in the intensive care unit
por: Hooten, Rorak, et al.
Publicado: (2019) -
Ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia in the intensive care unit
por: Maggiore, Christy, et al.
Publicado: (2015) -
Use of intravenous antibiotics for the treatment of community-acquired pneumonia in the emergency department
por: Carrie, Anita G, et al.
Publicado: (2005) -
879. Intravenous to Oral Antibiotic Switch in Patients Hospitalized with Community-Acquired Pneumonia
por: Deshpande, Abhishek, et al.
Publicado: (2022) -
Severe community-acquired pneumonia in the intensive care unit
por: Costa, C, et al.
Publicado: (2005)